Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Pharma Can Make the Most of Gene Tech CRISPR

Posted on December 18th, 2017 by in Pharma R&D

puzzle-2500333_960_720

The gene-editing technology CRISPR, which stands for ‘clustered regularly interspaced short palindromic repeats,’ is one of today’s most-talked-about scientific innovations. In just a few years, it’s gone from being a barely known entity to becoming a regular presence in scientific literature. (more…)

Chemists Concerned About How Their Field is Viewed

Posted on December 13th, 2017 by in Chemistry

Chemistry Opinion Survey 2017-12-11 15-06-07

Chemistry and its importance in everyday life is often underrated at best, and wildly misunderstood at worst. The stock image of scientists in white lab coats holding beakers of toxic chemicals has been hard to shake (more…)

As The Hive Evolves, More Companies Prepare to Join the Program

Posted on December 11th, 2017 by in Pharma R&D

This year, four companies working in early-stage drug development were able to power their efforts with an array of Elsevier tools by participating in The Hive. Now, more promising pharma and biotech start-ups are in the process of entering into The Hive (more…)

As Drug Development Costs Skyrocket, AI Offers Some Hope

Posted on November 20th, 2017 by in Pharma R&D

Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 7